Incyte (INCY) has been quietly outperforming the broader biotech space this year, with the stock up about 46% over the past year and more than 40% year to date, drawing fresh attention. See our latest ...

Incyte (INCY) shares soared 5.5% in the last trading session to close at $102.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

The 97th Academy Awards, also known as the 2025 Oscars, took place on a very special night that celebrated the biggest movies from 2024 and the incredible people who brought them to the big screen.

The Department of Health and Human Services has terminated seven grants totaling millions of dollars to the American Academy of Pediatrics, escalating its confrontation with the group, which is suing ...

Baker Brothers’ Q3 2025 13F portfolio rose to $13.84B, with high concentration in BeOne Medicines, Incyte, Madrigal Pharma, Insmed, and ACADIA Pharma. INCY, now ~19% of the portfolio, saw a marginal ...

Incyte Corporation (NASDAQ:INCY) Q2 2025 Earnings Call Transcript July 29, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.04, expectations were $1.39. Operator: Greetings, and ...

Investing.com - RBC Capital has reiterated its Sector Perform rating and $84.00 price target on Incyte (NASDAQ:INCY) following a visit to the company’s headquarters. This target sits notably below the ...